A randomized, double-blind, placebo-controlled clinical trial validating the effectiveness of Tendoease tablet in the rehabilitation of tendonitis. - NI

Meyer Organics Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•Subjects meeting all of the following criteria will be eligible for the study: 1. Male and female subjects aged between 16-50 years (both inclusive);2. Subjects with clinical or ultrasound-confirmed Achilles tendonitis, lateral epicondylitis or patellar tendonitis;3. Subject with relapse cases of tendinosis;4. Subjects with or without comorbidities, if comorbidity exists should be on stable prescription for more than three months;5. Willing to provide consent and willingness for follow-up.

•Subjects meeting any of the following criteria will not be eligible for the study:
•1. Preoperative shoulder fracture, irreparable tendon tear (Exceeding 50%),
•calcifying tendinitis, shoulder instability, acromioclavicular joint disorder,
•infection, neoplasm, symptomatic cervical spine disease, rheumatoid
•arthritis or immune disease, gout or uric acid disease;
•2. Subjects allergic to the investigational product ingredients;
•3. Subjects with any acute illness requiring immediate medical care;
•4. Subjects with uncontrolled diabetes/ complicated cardiovascular
•diseases/ history of TIA, cerebrovascular accident, stroke or any
•revascularization;
•5. Known subjects of hepatic or renal impairments;
•6. Pregnant, breastfeeding or planning to become pregnant during the study;
•7. Any other condition which proves subject unfit for the study
•participation.

发起方

Meyer Organics Pvt Ltd